Sheffield Kent, MD
Pain Medicine · Conway, ARNPI 1679831440
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $10,087 of the $16,202 with a category attached, or 62.3%. 26 manufacturers reported payments, led by Boston Scientific at 57.0% of the total. Reporting peaked in 2019 at $5,054 and has fallen 90.1% since, to $499 in 2025.
Across 326 payments — averaging $49.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$9K
- Nevro Corp.$4K
- Abbott$779
- Vertos Medical, Inc.$547
- Collegium Pharmaceutical, Inc.$492
- Providence Medical Technology, Inc.$223
- plus $885 from 20 others
Across 1 payment — averaging $122.68 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Saluda Medical Americas, Inc.$123
What the payments were for
- Consulting fees$3,60022%
- Travel & lodging$2,51216%
- Food & beverage$10,08762%
- Education$30%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 147 | $9,235 |
| Nevro Corp. | 80 | $4,042 |
| Abbott | 25 | $779 |
| Vertos Medical, Inc. | 3 | $547 |
| Collegium Pharmaceutical, Inc. | 26 | $492 |
| Providence Medical Technology, Inc. | 3 | $223 |
| Stryker | 4 | $177 |
| Medtronic(2 entities) | 5 | $116 |
| Redhill Biopharma Inc. | 7 | $109 |
| Globus Medical | 3 | $87 |
| Johnson & Johnson | 2 | $51 |
| Vertex | 2 | $45 |
| Biodelivery Sciences International, Inc. | 3 | $40 |
| GRT US Holding, Inc. | 2 | $34 |
| Si-bone, Inc. | 1 | $29 |
| Averitas Pharma Inc. | 1 | $25 |
| Saluda Medical Americas, Inc. | 2 | $24 |
| Virtus Pharmaceuticals LLC | 1 | $20 |
| Painteq LLC | 1 | $18 |
| Relievant Medsystems, Inc. | 1 | $18 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $18 |
| Pacira Therapeutics, Inc. | 1 | $17 |
| Pfizer | 1 | $15 |
| Stimwave Technologies Incorporated | 2 | $15 |
| Spinal Simplicity, LLC | 1 | $13 |
| Zyla Life Sciences, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SPECTRA WAVEWRITER$4,559
- Omnia$1,410
- Senza$1,158
- SUPERION$1,115
- GENERAL PAIN MANAGEMENT$675
- mild Device Kit$476
- ETERNA$168
- WaveWriter Alpha Prime 16$147
- IonicRF$139
- PROCLAIM$138
- WAVEWRITER ALPHA$125
- Superion Indirect Decompression System$124
- MULTIGEN 2$115
- Octrode SCS Leads$108
How this compares
$16,202 in reported general payments places this provider in the 85th percentile of 53 pain medicine providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| NucyntaTapentadol Hcl | 57 | $60,194 |
| Nucynta ErTapentadol Hcl | 13 | $19,274 |
| BelbucaBuprenorphine Hcl | 25 | $19,024 |
| Xtampza ErOxycodone Myristate | 14 | $9,698 |
| OxycontinOxycodone Hcl | 12 | $9,262 |
| Buprenorphine | 41 | $9,235 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 264 | $9,002 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 387 | $8,158 |
| Gabapentin | 258 | $4,511 |
| Pregabalin | 163 | $3,501 |
| Tizanidine Hcl | 204 | $2,060 |
| Tramadol Hcl | 283 | $1,978 |
| Diclofenac Sodium | 81 | $1,244 |
| Amitriptyline Hcl | 93 | $1,132 |
| Oxycodone Hcl | 91 | $1,129 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Nucynta, Nucynta Er, Belbuca, Xtampza Er | $492 | $108,189109 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 53 pain medicine providers in Arkansas.
Other pain medicine in Conway
- George ArcosConway$30K
- Daniel JudkinsConway$17K
- Thomas WardConway$1K
- Richard MooreConway$45
- Stephen PaulusLittle Rock$75K
- Mark MiedemaFayetteville$35K
- George DeimelFayetteville$26K
- Julio OlayaLittle Rock$22K
- Maria Lyuksyutova-PriceMountain Home$19K
- Christopher MocekLittle Rock$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.